VERA Vera Therapeutics Inc
- Stocks
- Healthcare
- NASDAQ: VERA
Price (delayed)
$24.1
Market cap
$1.54B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.58
Enterprise value
$1.57B
Relative Growth:
1
Relative Strength:
27
Relative Valuation:
N/A
Relative Profitability:
3
Highlights
VERA's equity is up by 43% year-on-year but it is down by 12% since the previous quarter
The net income has plunged by 102% YoY and by 24% from the previous quarter
VERA's EPS has dropped by 62% year-on-year and by 19% since the previous quarter
Key stats
What are the main financial stats of VERA
Market
Valuations
Earnings
Shares outstanding
63.82M
Market cap
$1.54B
Enterprise value
$1.57B
Price to earnings (P/E)
N/A
Price to book (P/B)
3.28
Price to sales (P/S)
N/A
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$236.05M
Net income
-$218.28M
EBIT
-$210.81M
EBITDA
-$208.58M
Free cash flow
-$186.55M
Per share
Balance sheet
Liquidity
EPS
-$3.58
EPS diluted
-$3.58
Free cash flow per share
-$2.92
Book value per share
$7.34
Revenue per share
$0
TBVPS
$9.07
Total assets
$578.53M
Total liabilities
$110.25M
Debt
$77.55M
Equity
$468.28M
Working capital
$537.8M
Debt to equity
0.17
Current ratio
17.03
Quick ratio
16.59
Net debt/EBITDA
-0.14
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-39.5%
Return on equity
-46.7%
Return on invested capital
-39.7%
Return on capital employed
-38.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VERA stock price
How has the Vera Therapeutics stock price performed over time
Intraday
-1.03%
1 week
-17.92%
1 month
-20.04%
1 year
-49.48%
YTD
-43.01%
QTD
-17.07%
Financial performance
How have Vera Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$236.05M
Net income
-$218.28M
Gross margin
N/A
Net margin
N/A
The net income has plunged by 102% YoY and by 24% from the previous quarter
VERA's operating income has dropped by 101% year-on-year and by 22% since the previous quarter
Price vs fundamentals
How does VERA's price correlate with its fundamentals
Growth
What is Vera Therapeutics's growth rate over time
Valuation
What is Vera Therapeutics stock price valuation
P/E
N/A
P/B
3.28
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
VERA's EPS has dropped by 62% year-on-year and by 19% since the previous quarter
VERA's equity is up by 43% year-on-year but it is down by 12% since the previous quarter
VERA's P/B is 36% less than its 5-year quarterly average of 5.1 and 32% less than its last 4 quarters average of 4.8
Efficiency
How efficient is Vera Therapeutics business performance
The ROIC has contracted by 16% from the previous quarter and by 8% YoY
VERA's return on equity is down by 15% since the previous quarter
The ROA has declined by 14% since the previous quarter and by 7% year-on-year
Dividends
What is VERA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VERA.
Financial health
How did Vera Therapeutics financials performed over time
The total liabilities has surged by 59% year-on-year and by 47% since the previous quarter
VERA's total assets is up by 46% year-on-year but it is down by 5% since the previous quarter
VERA's debt is 83% smaller than its equity
Vera Therapeutics's debt to equity has surged by 70% QoQ and by 6% YoY
VERA's debt is up by 47% year-on-year and by 42% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.